1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Blood Screening Market Outlook
4.1.
Market Size &
Forecast
4.1.1. By Value
4.2.
Market Share &
Forecast
4.2.1. By Technology (Nucleic
Acid Amplification Test (NAT), ELISA, Chemiluminescence Immunoassay (CLIA) and
Enzyme Immunoassay (EIA), Next Generation Sequencing (NGS), Western Blotting)
4.2.2. By Product (Reagent, Instrument)
4.2.3. By
Region
4.2.4. By Company (2023)
4.3.
Market Map
4.3.1. By Technology
4.3.2. By Product
4.3.3. By Region
5. Asia Pacific Blood Screening Market Outlook
5.1.
Market Size &
Forecast
5.1.1. By Value
5.2.
Market Share &
Forecast
5.2.1. By
Technology
5.2.2. By
Product
5.2.3. By Country
5.3.
Asia Pacific:
Country Analysis
5.3.1. China Blood Screening Market Outlook
5.3.1.1.
Market Size & Forecast
5.3.1.1.1.
By Value
5.3.1.2.
Market Share & Forecast
5.3.1.2.1.
By Technology
5.3.1.2.2.
By Product
5.3.2. India Blood Screening Market Outlook
5.3.2.1.
Market Size & Forecast
5.3.2.1.1.
By Value
5.3.2.2.
Market Share & Forecast
5.3.2.2.1.
By Technology
5.3.2.2.2.
By Product
5.3.3. Australia Blood Screening Market Outlook
5.3.3.1.
Market Size & Forecast
5.3.3.1.1.
By Value
5.3.3.2.
Market Share & Forecast
5.3.3.2.1.
By Technology
5.3.3.2.2.
By Product
5.3.4. Japan Blood Screening Market Outlook
5.3.4.1.
Market Size & Forecast
5.3.4.1.1.
By Value
5.3.4.2.
Market Share & Forecast
5.3.4.2.1.
By Technology
5.3.4.2.2.
By Product
5.3.5. South Korea Blood Screening Market Outlook
5.3.5.1.
Market Size & Forecast
5.3.5.1.1.
By Value
5.3.5.2.
Market Share & Forecast
5.3.5.2.1.
By Technology
5.3.5.2.2.
By Product
6. Europe Blood Screening Market Outlook
6.1.
Market Size &
Forecast
6.1.1. By Value
6.2.
Market Share &
Forecast
6.2.1. By
Technology
6.2.2. By
Product
6.2.3. By
Country
6.3.
Europe: Country
Analysis
6.3.1. France Blood Screening Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Technology
6.3.1.2.2.
By Product
6.3.2. Germany Blood Screening Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Technology
6.3.2.2.2.
By Product
6.3.3. Spain Blood Screening Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Technology
6.3.3.2.2.
By Product
6.3.4. Italy Blood Screening Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Technology
6.3.4.2.2.
By Product
6.3.5. United Kingdom Blood Screening Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Technology
6.3.5.2.2.
By Product
7. North America Blood Screening Market Outlook
7.1.
Market Size &
Forecast
7.1.1. By Value
7.2.
Market Share &
Forecast
7.2.1. By
Technology
7.2.2. By
Product
7.2.3. By Country
7.3.
North America:
Country Analysis
7.3.1. United States Blood Screening Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Technology
7.3.1.2.2.
By Product
7.3.2. Mexico Blood Screening Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Technology
7.3.2.2.2.
By Product
7.3.3. Canada Blood Screening Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Technology
7.3.3.2.2.
By Product
8. South America Blood Screening Market Outlook
8.1.
Market Size &
Forecast
8.1.1. By Value
8.2.
Market Share &
Forecast
8.2.1. By
Technology
8.2.2. By
Product
8.2.3. By Country
8.3.
South America:
Country Analysis
8.3.1. Brazil Blood Screening Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Technology
8.3.1.2.2.
By Product
8.3.2. Argentina Blood Screening Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Technology
8.3.2.2.2.
By Product
8.3.3. Colombia Blood Screening Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Technology
8.3.3.2.2.
By Product
9. Middle East and Africa Blood Screening Market Outlook
9.1.
Market Size &
Forecast
9.1.1. By Value
9.2.
Market Share &
Forecast
9.2.1. By
Technology
9.2.2. By
Product
9.2.3. By Country
9.3.
MEA: Country
Analysis
9.3.1. South Africa Blood Screening Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Technology
9.3.1.2.2.
By Product
9.3.2. Saudi Arabia Blood Screening Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Technology
9.3.2.2.2.
By Product
9.3.3. UAE Blood Screening Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Technology
9.3.3.2.2.
By Product
10.
Market Dynamics
10.1. Drivers
10.2. Challenges
11.
Market Trends &
Developments
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12.
Global Blood
Screening Market: SWOT Analysis
13. Porter’s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product
14.
Competitive
Landscape
14.1. Abbott Laboratories Inc.
14.1.1.
Company Snapshot
14.1.2.
Product &
Services
14.1.4.
Financials (In case
of listed)
14.1.5.
Recent Developments
14.1.6.
SWOT Analysis
14.2. Danaher Corporation (Beckman Coulter)
14.3. Becton Dickinson and Company
14.4. Bio-Rad Laboratories, Inc.
14.5. Hoffman-La Roche Ltd.
14.6. Grifols, S.A.
14.7. Ortho-Clinical Diagnostics, Inc.
14.8. Siemens Healthineers AG
14.9. Thermo Fisher Scientific, Inc.
14.10.SOFINA s.a (Biomerieux)
15. Strategic Recommendations
16. About Us & Disclaimer